Aktuellt
SENASTE
Redeye embraces BONESUPPORT’s Q1 report, showing a remarkable growth of 48% y/y, primarily driven by the North American segment's aggressive 64% y/y sales growth. Net sales came in at SEK 66.3m vs RE estimate of SEK 65.6, with EBIT at SEK -16.5m vs RE estimate of SEK -16.0m. We note additional nuggets in the report, which we will unravel in more detail in a coming update following a chat with management and the conference call. We expect the stock to react positively and believe it should close some +5-10% for the day.
LÄS MER
